Socio-economic burden of cardiovascular diseases in Poland and Central Europe
More details
Hide details
Zakład Statystyki, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej w Sosnowcu, Śląski Uniwersytet Medyczny w Katowicach
Fysiologiska Kliniken Diagnostisk Centrum, Kalmar län, Szwecja
Piotr Stanisław Choręza   

Zakład Statystyki, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej w Sosnowcu, Śląski Uniwersytet Medyczny w Katowicach, ul. Ostrogórska 30, 41-200 Sosnowiec
Ann. Acad. Med. Siles. 2018;72:216–223
Cardiovascular diseases cause over 4 million deaths each year in the societies of fifty-three countries of the World Health Organization’s European region. Over 1.9 million deaths occur in European Union countries. In 2010, the Organization for Economic Co-operation and Development reported that 13% of deaths in European Union countries were a consequence of coronary artery disease. The aim of the work was to analyze the socio-economic burden of cardiovascular diseases as well as the sources and costs of the healthcare in Poland and selected Central European countries.

Material and Methods:
European Statistical Office and Polish Central Statistical Office data were analyzed. The literature data comes from journals indexed in the Medline database.

The European Union’s economic burden of cardiovascular diseases was estimated at € 210 billion in 2015. The biggest part of that – 52% – was healthcare expenditures, 25% was lost productivity and 21% was private care costs. The amount of funds allocated to cardiovascular disease therapy by European Union countries is highly diversified. Cardiovascular diseases absorb 16% of funds allocated for the healthcare system in Poland, while only 3% in Denmark and Sweden, 7% and 8% in France and Germany respectively and about 12% in Central European countries, e.g. the Czech Republic and Slovakia, and 19% in Hungary. A growth in state healthcare expenditures was one of the consequences of Poland’s accession to the European Union. According to the European Statistical Office, Poland spent over € 18.45 billion, that is 4.49% of the Gross Domestic Product, on the healthcare system in 2014.

Townsed N., Wilson L., Bhatnagar P., Wickramasinghe K., Rayner M., Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur. Heart J. 2016; 37(42): 3232–3245, doi: 10.1093/eurheartj/ehw334.
Ferreira-González I. The epidemiology of coronary heart disease. Rev. Esp. Cardiol. 2014; 67(2): 139–144, doi: 10.1016/j.rec.2013.10.002.
Nichols M., Townsend N., Scarborough P., Rayner M. Cardiovascular disease in Europe: epidemiological update. Eur. Heart J. 2013; 34(39): 3028–3034, doi: 10.1093/eurheartj/eht356.
Leal J., Luengo-Fernández R., Gray A., Petersen S., Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur. Heart J. 2006; 27(13): 1610–1619, doi: 10.1093/eurheartj/ehi733.
Bansilal S., Castellano J.M., Fuster V. Global burden of CVD: focus on secondary prevention of cardiovascular disease. Int. J. Cardiol. 2015; 201(Suppl. 1): S1–S7, doi: 10.1016/S0167-5273(15)31026-3.
Europejski Urząd Statystyczny [on-line], dostępne: [Dostęp: 06.09.2017 r.].
Suhrcke M., Urban D. Are cardiovascular diseases bad for economic growth? Health Econ. 2010; 19(12): 1478–1496, doi: 10.1002/hec.1565.
Slavici T., Avram C., Mnerie G.V., Badescu A., Darvasi D., Molnar-Matei F., Ungureanu M.A. Economic efficiency of primary care for CVD prevention and treatment in Eastern European countries. BMC Health Serv. Res. 2013; 13: 75, doi: 10.1186/1472-6963-13-75.
Wilsgaard T., Loehr L.R., Mathiesen E.B., Løchen M.L., Bønaa K.H., Njølstad I., Heiss G. Cardiovascular health and the modifiable burden of incident myocardial infarction: the Tromsø Study. BMC Public Health 2015; 15: 221, doi: 10.1186/s12889-015-1573-0.
Jelani A., Jugdutt B.I. STEMI and heart failure in the elderly: role of adverse remodeling. Heart Fail. Rev. 2010; 15(5): 513–521, doi: 10.1007/s10741-010-9177-3.
Ulusoy F.R., Yolcu M., Ipek E., Korkmaz A.F., Gurler M.Y., Gulbaran M. Coronary artery disease risk factors, coronary artery calcification and coronary bypass surgery. J. Clin. Diagn. Res. 2015; 9(5): OC06–OC10, doi: 10.7860/JCDR/2015/12081.5989.
Wilkins E., Wilson L., Wickramasinghe K., Bhatnagar P., Leal J., Luengo-Fernandez R., Burns R., Rayner M., Townsend N. (2017). European Cardiovascular Disease Statistics 2017. European Heart Network, Brussels.
Rivera B., Currais L. Economic growth and health: direct impact or reverse causation? Appl. Econ. Lett. 1999; 6(11): 761–764.
Knowles S., Owen P.D. Education and health in an effective-labour empirical growth model. Economic Record 1997; 73(223): 314–328.
Główny Urząd Statystyczny. Rocznik Statystyczny Rzeczypospolitej Polskiej 2015 [on-line],